Meta-Analysis | Mapi Research Trust

Articles

2017. Guyot P et al. – Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies
2017. Rosen VM et al – Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
2017. Huisman E et al. – Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis
2017. Papadimitropoulou K et al. – Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: A systematic review and network meta-analysis
2017. Bergrath E et al. – Tofacitinib versus biologic treatments in moderate-to-severe rheumatoid arthritis patients who have had an inadequate response to nonbiologic DMARDs: Systematic literature review and network meta-analysis
2017. Burnett H et al. – Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: A network meta-analysis
2016. Vieira MC et al. – Tofacitinib versus biologic treatments in patients with active rheumatoid arthritis who have had an inadequate response to tumor necrosis factor inhibitors: Results from a network meta-analysis
2016. Linneberg A et al. – Burden of allergic respiratory disease: A systematic review
2016. Jansen JP et al. – Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis
2016. Karabis A et al. – High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: Meta-analysis and implications
2016. de La Loge C et al. – Relationship between FEV1 and patient-reported outcomes changes: Results of a meta-analysis of randomized trials in stable COPD
2015. Ismaila AS et al. – Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: A systematic review and network meta-analysis
2015. Huisman EL et al. – Comparative efficacy of combination bronchodilatator thrapies in COPD: A network meta-analysis
2015. Buckley F et al. – Comparative efficacy of novel DMARDs as monotherapy and in combination with methotrexate in rheumatoid arthritis patients with inadequate response to conventional DMARDs: A network meta-analysis
2015. van Walsem A et al. – Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: A network meta-analysis
2014. Panagiotopoulou N et al. – Uterine-sparing minimally invasive interventions in women with uterine fibroids: A systematic review and indirect treatment comparison meta-analysis
2014. Cope S et al. – A process for assessing the feasibility of a network meta-analysis: A case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
2014. Zeppetella G et al. – A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes
2013. Cope S et al. – Comparative efficacy of long-acting bronchodilators for COPD – A network meta-analysis
2013. Kinnaird T et al. – Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: A network meta-analysis
2013. Schouten HJ et al. – Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: Systematic review and meta-analysis
2013. Cope S et al. – Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second line treatment for advanced breast cancer – A network meta-analysis with parametric survival models
2013. Karabis A et al. – Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: A systematic review and network meta-analysis
2013. Medic G et al. – Dosing frequency and adherence in chronic psychiatric disease: Systematic review and meta-analysis
2012. Littlewood KJ et al. – A network meta-analysis of the efficacy of inhaled antibiotics for chronic pseudomonas infections in cystic fibrosis
2012. Jansen JP – Network meta-analysis of individual and aggregate level data
2012. Cope S et al. – Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
2012. Matlaga BR et al. – Treatment of ureteral and renal stones: A systematic review and meta-analysis of randomized, controlled trials
2012. Cope S et al. – Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol/budesonide or salmeterol/fluticasone for COPD: A network meta-analysis
2012. Dequen et al. – Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma
2011. Guyot P et al. – Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: A network meta-analysis
2011. Guyot P et al. – Survival time outcomes in randomized, controlled trials and meta-analyses: The parallel universes of efficacy and cost-effectiveness
2011. Cope S et al. – Comparative efficacy of indacaterol 150 µg and 300 µg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – A network meta-analysis
2011. Jansen JP – Network meta-analysis of survival data with fractional polynomials
2011. Jansen JP et al. – The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: A network meta-analysis
2010. Ouwens MJ et al. – Network meta-analysis of parametric survival curves
2010. Bergman GJ et al. – Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: A meta-analysis
2008. Jansen JP et al. – Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons

Posters & Presentations

2017. ACR/ARHP Annual Meeting – Presence of Anti-Cyclic Citrullinated Peptide Antibodies Is Associated with Better Treatment Response to Abatacept but Not to TNF Inhibitors in Patients with RA: A Meta-Analysis
2017. ISPOR European Congress – Network meta-analysis in the evaluation of vaccines
2016. ISPOR European Congress – Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods
2016. ERS International Congress – Comparative Efficacy of Umeclidinium/Vilanterol versus LABA/LAMA Therapies in COPD: A Network Meta-Analysis
2016. EULAR Annual Congress – Tofacitinib Versus Biologic Treatments in Moderate to Severe Rheumatoid Arthritis Patients who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis
2015. ISPOR European Congress – Comparative Efficacy of Ketamine and Other Pharmacological and Somatic Interventions in Adult Patients with Treatment-Resistant Depression: A Network Meta-Analysis
2014. ISPOR European Congress – The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta- Analysis Comparing Pharmacological Treatments for Chronic Heart Failure
2014. ISPOR European Congress – Systematic Review of Observational Studies and RCTs of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment
2014. ISPOR European Congress – Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials
2014. ISPOR Annual European Congress – Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analysis of Moderate to Severe Chronic Plaque Psoriasis Trials
2014. Biannual International Multidisciplinary Pain Congress – Comparative efficacy of non-steroidal anti-inflammatory drugs in pain relief: Results of a systematic literature review and network meta-analysis
2014. Mediterranean Congress of Rheumatology – Comparative Efficacy and Safety of Diclofenac Versus Naproxen in Pain Relief: Results of a Systematic Literature Review and Network Meta-Analysis
2014. ISPOR Annual International Meeting – A Network Meta-Analysis Evaluating the Cumulative Hazard Rate of Stroke or Systemic Embolism for New Oral Anticoagulants in Stroke Prevention for Atrial Fibrillation
2014. ISPOR Annual International Meeting – Comparability of Trial Populations in Network Meta-Analyses Assessing Biologic Treatments in Moderate to Severe Plaque Psoriasis
2014. ISPOR Annual International Meeting – Comparative Efficacy of Novel DMARDs as Monotherapy in Rheumatoid Arthritis Patients with an Inadequate Response to Traditional DMARDs – A Network Meta-Analysis
2014. ESC Heart Failure Congress – Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations: Network Meta-Analyses.
2013. ISPOR European Congress – Network Meta-Analysis with Fractional Polynomials for Repeated Trough FEV1 Measures in COPD: Aclidinium Bromide 400 μg Bid Versus Tiotropium 18 μg QD
2013. ISPOR European Congress – Efficacy of Inhaled Antibiotics in CF Patients with Chronic P. Aeruginosa Infection: A Network Meta-Analysis
2013. ISPOR European Congress – Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival
2013. ISPOR European Congress – Network Meta-Analysis of Approved Biologic Interventions for the Induction of Response in Ulcerative Colitis
2013. ISPOR European Congress – Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis
2013. ISPOR European Congress – Assessing Non-Inferiority of Aclidinium Bromide 400 μg Bid Versus Tiotropium 18 μg and 5 μg QD in Patients with Chronic Obstructive Pulmonary Disease (COPD) by Means of a Network Meta-Analysis
2013. ACR/AHRP Annual Meeting – Comparative Efficacy Of Novel Disease-Modifying Antirheumatic Drugs As Monotherapy and In Combination With Methotrexate In Rheumatoid Arthritis Patients With An Inadequate Response To Traditional Disease-Modifying Antirheumatic Drugs: A Network Meta-Analysis
2013. ISPOR Latin America Conference – Advances in Meta-Analysis: Incorporating Multiple Treatments, Multiple Endpoints, and Multiple Study Designs
2013. European Society of Cardiology Congress – Relative efficacy of bivalirudin vs. heparin monotherapy in STEMI patients treated with primary percutaneous coronary intervention. A network meta-analysis
2013. ISPOR Annual International Meeting – Assessing Network Meta Analysis Studies For Health Care Decisions
2013. ISPOR Annual International Meeting – Incorporating Patient Level Data in a Network Meta-Analysis
2013. ISPOR Annual International Meeting – Network Meta-Analysis of Longitudinal Data
2013. ISPOR Annual International Meeting – Network Meta-Analysis of Survival Data. The Value of Reconstructing Data from Published Kaplan-Meier Curves
2012. ACR/AHRP Annual Meeting – Comparative efficacy of biologics as monotherapy and in combination with methotrexate in rheumatoid arthritis patients with an inadequate response to conventional DMARDs: A network meta-analysis
2012. ISPOR European Congress – Dual bronchodilation with indacaterol and tiotropium in combination versus triple therapy, fixed-dose combinations, and monotherapy in COPD. A network meta-analysis of FEV1
2012. ISPOR European Congress – Comparative efficacy of Aclidinium Bromide 400 µg bid versus Tiotropium 18 µg and 5 µg QD as maintenance bronchodilatator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD): A network meta-analysis
2012. ISPOR European Congress – Comparative Efficacy of Tocilizumab and Anti-TNF Biologic Monotherapies on Patient-Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDS (DMARD-IR): A Network Meta-Analysis
2012. ISPOR European Congress – Comparing the efficacy and safety of biologics for the treatment of rheumatoid arthritis patients: a network meta-analysis
2012. ISPOR European Congress – Health Evidence for Decision-Making: Assessment Tool for Network Meta-Analysis
2012. ISPOR European Congress – Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients: A Network Meta-Analysis
2012. ISPOR European Congress – Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Community-Acquired Pneumonia (CAP): A Network Meta-Analysis (NMA)
2012. ISPOR European Congress – Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis (NMA)
2012. ISPOR European Congress – Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations: Network Meta-Analyses
2012. EULAR Annual European Congress – Tofacitinib versus biologic treatments with and without methotrexate in patients with active rheumatoid arthritis who have had an inadequate response to traditional disease modifying anti-rheumatic drugs. A network meta-analysis
2012. EULAR Annual European Congress – Meta-analysis of joint structural deterioration over time in minimally treated rheumatoid arthritis patients
2012. EAPC World Research Congress – Choosing between treatments: The role of indirect treatment comparisons and network meta-analysis in healthcare decision-making
2012. ISPOR Annual International Meeting – Meta-Analysis Combining Individual Participant Data (IPD) and Aggregated Data (AD)
2012. ISPOR Annual International Meeting – Dopamine Agonists and Dyskinesia in Advanced Parkinson’s Disease: A Network Meta-Analysis of Rotogotine, Pramipexole and Ropinirole as Adjunct Therapy to Levodopa
2012. ISPOR Annual International Meeting – Assessing Network Meta-Analysis Studies: A Proposed Tool for Health Care Decision-Makers
2012. ISPOR Annual International Meeting – Network Meta-Analysis of Studies with Outcomes at Multiple Points Using Fractional Polynomials
2012. ISPOR Annual International Meeting – Meta-Regression Models to Address Heterogeneity and Inconsistency in Network Meta-Analysis of Survival Outcomes
2012. ISPOR Annual International Meeting – How to Present the Probability of Being the Best Treatment in the Context of a Bayesian Network Meta-Analysis of Parametric Survival Curves
2012. ISPOR Annual International Meeting – Network Meta-Analysis of Individual and Aggregated Level Data
2012. ASCPT Annual Meeting – Evaluation of the value of biologics. Integration of comparative and cost-effectiveness analysis with network meta-analysis
2011. ISPOR Annual International Meeting – Conducting and Interpreting Indirect Treatment Comparison and Network Meta-Analysis: Learning the Basics
2010. ISPOR European Congress – Workshop: Conducting and Interpreting Indirect Treatment Comparison and Network Meta-Analysis: Learning the Basics
2008. ISPOR Asia-Pasific Conference – Meta-Analysis Methods that Allow for Comparison of Interventions in the Absence of Head-to-Head Data
2008. ISPOR Annual International Meeting – Advances in Meta-Analysis: Techniques for Including Multiple Study Designs, Multiple Endpoints, and Multiple Treatments